Superstring Capital Management LP Avidity Biosciences, Inc. Transaction History
Superstring Capital Management LP
- $84.5 Billion
- Q2 2025
A detailed history of Superstring Capital Management LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 47,037 shares of RNA stock, worth $2.08 Million. This represents 1.58% of its overall portfolio holdings.
Number of Shares
47,037
Previous 22,271
111.2%
Holding current value
$2.08 Million
Previous $657 Million
103.19%
% of portfolio
1.58%
Previous 0.78%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
232Shares Held
119MCall Options Held
340KPut Options Held
145K-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$478 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X010.8MShares$476 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY9.62MShares$425 Million4.2% of portfolio
-
Wellington Management Group LLP Boston, MA9.25MShares$409 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$409 Million0.0% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.3B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...